Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 CAD | 0.00% | 0.00% | +5.88% |
09/04 | Rakovina Therapeutics Presents At American Association Of Cancer Research Annual Meeting | MT |
2023 | Rakovina Therapeutics Announces Appointment to Scientific Advisory Board | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mads Daugaard
PSD | President | - | 01/21/01 |
David Hyman
DFI | Director of Finance/CFO | - | - |
John Langlands
COO | Chief Operating Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 06/19/06 | |
Jeffrey Bacha
CHM | Chairman | 56 | 01/20/01 |
Dennis Brown
BRD | Director/Board Member | 74 | 25/21/25 |
Michael Liggett
BRD | Director/Board Member | - | 25/21/25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 70,084,925 | 38,017,157 ( 54.24 %) | 0 | 54.24 % |
Company contact information
Rakovina Therapeutics, Inc.
1008 Beach Avenue Suite 105
V6E 1T7, Vancouver
+
http://www.rakovinatherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+5.88% | 4.61M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RKV Stock
- Company Rakovina Therapeutics Inc.